首页 | 本学科首页   官方微博 | 高级检索  
     

我国建立药品不良反应损害救济机制的研究
引用本文:杨悦,蒋志刚,李野. 我国建立药品不良反应损害救济机制的研究[J]. 中国新药杂志, 2010, 0(9)
作者姓名:杨悦  蒋志刚  李野
作者单位:沈阳药科大学工商管理学院;辽宁中沈医药新产品有限公司;
摘    要:探讨建立综合性药品不良反应(adverse drug reactions,ADR)损害补偿机制。分析我国ADR损害赔偿的困境和原因,借鉴典型国家和中国台湾地区ADR损害救济的经验。目前,我国ADR的司法和补偿救济途径不畅通,我国应建立的是由司法、补偿救济、保险等途径同时发挥作用的ADR补偿救济机制。

关 键 词:药品不良反应  损害  救济  

To establish adverse drug reactions damage compensation system in China
YANG Yue,JIANG Zhi-gang,,LI Ye. To establish adverse drug reactions damage compensation system in China[J]. Chinese Journal of New Drugs, 2010, 0(9)
Authors:YANG Yue  JIANG Zhi-gang    LI Ye
Affiliation:YANG Yue1,JIANG Zhi-gang1,2,LI Ye1(1 School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China,2 Liaoning Zhongshen Medicinal New Production Co.,Ltd.,Shenyang 110002,China)
Abstract:To establish the adverse drug reactions(ADR) damage compensation system,we analyzed the scrape and reason for ADR damage compensation,and referred to ADR relief experience of model countries and China Taiwan.At present,the approaches through justice and relief are not smooth,so we should establish an ADR damage compensation system including justice,relief and insurance jointly function.
Keywords:adverse drug reactions(ADR)  damage  compensation  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号